A revenue-generating, small-cap Canadian pharmaceutical company

Revenue Projected at $150,000,000 by 2025

Free
Message: AGORACOM Small Cap 60: Was A Record Year, Valeo Pharma (VPH: CSE) Management Is Never Satisfied

Share
New Message
Please login to post a reply